Chapter 22: Cholinergic-Blocking Drugs – Anticholinergic Effects
Welcome to Last Minute Lecture.
This free chapter overview is designed to help students review and understand key concepts.
These summaries supplement not replaced the original textbook and may not be redistributed or resold.
For complete coverage, always consult the official text.
Welcome to the Deep Dive.
Today we are tearing into a really critical class of pharmaceuticals.
We're talking about the ones that basically slam the brakes on your body's relaxation mode.
That's right, the cholinergic blockers.
Yeah, or anti -cholinergics, parasympathalytics, they seem to have a lot of names.
They do.
And our mission today really is clarity,
because these drugs, they're everywhere in medicine,
but their effects are so widespread, so systemic, it gets complicated fast.
Okay.
So we'll walk through how they work, the risks, the crucial nursing insights.
The goal is to make sure you really grasp what happens when you block that parasympathetic nervous system, the rest and digest,
and let the sympathetic fight or flight system can take the wheel.
Got it.
So let's nail down the terms first.
Cholinergic blocking drugs that specifically targets acetylcholine, right?
Osses.
Exactly.
Osses is the main messenger for the parasympathetic system.
And these drugs block its action at the receptor sites.
And parasympathetic just means reducing PNS activity.
Precisely.
And if you need a quick visual sign, think of my drassus.
E.
poly -dupe.
Yep, that immediate widening of the pupil.
It's a classic sign, the body shifting gears because of these drugs.
Okay.
Let's get into the nuts and bolts, the pharmacology.
If ACH is the key for rest and digest, how do these drugs actually stop it?
It's actually quite elegant mechanism -wise.
It's called competitive antagonists.
Competitive, okay.
Think of them as, well, ultimate competitors.
They flood the system and they fight AC for the parking spots, primarily the muscarinic receptors.
Okay, so AC needs that spot to talk to the heart, the gut, the bladder.
Right.
And the cholinergic blocker basically steals that spot.
It binds there instead.
So it's like they've, I don't know, permanently towed AC's car away.
Yeah, something like that.
And because they occupy that receptor, the normal parasympathetic effect, you know, slowing the heart, boosting gut activity, it just can't happen.
Right.
But here's the critical thing.
By blocking the PNS, you essentially unleash the sympathetic nervous system.
Ah, so the effects end up looking like adrenergic drugs, like adrenaline.
Exactly.
Increased heart rate, relaxed, smooth muscle.
It's the sympathetic show running unopposed.
And that systemic takeover explains why they affect, well, almost everything.
If we look at the effects listed in the sources, it's like the opposite of resting.
Let's tick through the systems, maybe starting with the heart.
Okay.
Cardiovascular.
It's a bit weird with dosage.
Small doses might briefly slow the heart rate down.
Really?
That seems counterintuitive.
It does, but the main effect therapeutically and toxically comes from larger doses.
They strongly block the vagus nerve's inhibitory signals to the heart, making the heart rate speed up, sometimes quite significantly.
Okay.
And respiratory.
You mentioned these are useful there.
Oh, very useful.
They decrease bronchial secretions, less mucus, and importantly cause bronchodilation, opening up the airways.
Which is great for things like COPD, asthma.
It's a big benefit there.
Okay.
Moving down to the gut, the GI system.
Expect to slow down.
Decreased motility, less peristalsis, reduced gastric secretions, clinically.
That usually means constipation.
Right.
And the GU system, the bladder.
Similar relaxing effect.
The main bladder muscle, the detrusor, relaxes, but the internal sphincter tightens up.
So the bladder doesn't squeeze and the exit is tighter.
Which leads directly to urinary retention.
Difficulty peeing or not being able to pee at all.
And back to the eyes.
We said midriasis, the dilated pupils, but there's more, isn't there?
Cycloplegia?
Yes.
Cycloplegia.
That's paralysis of the eye muscle that controls focusing.
Ah, so that's why people get blurred vision.
Precisely.
The pupil's wide open, letting in lots of light, and the eye can't adjust focus.
Makes reading tough.
And crucially, this whole process increases the pressure inside the eye.
Which is why it's a huge problem for people with angle closure glaucoma.
Absolute contraindication.
Dangerously high pressure.
Okay.
And finally, the CNS effects.
The brain.
It's dose dependent again.
Small doses can actually be helpful.
Decreasing muscle rigidity tremors.
We'll get to Parkinson's uses.
But large doses.
That's where it gets risky.
Drowsiness, disorientation, even serious hallucinations.
And that cognitive piece you mentioned that's especially important for older adults.
Critically important.
That sensitivity is a major focus when we talk about safety later on.
Okay.
Good point.
Let's shift to where we actually use these effects.
What are the main therapeutic applications?
Well, in the CNS, it's often about correcting neurotransmitter imbalances.
So treating Parkinson's disease, helping with that rigidity and tremor.
And also for drug -induced extra -pyranidal reactions.
You know, those movement side effects you can get from some antipsychotic meds.
Right.
They block their relative excess of a she in those cases.
Exactly.
Helps modulate movement.
And then there's atropine.
That feels like the poster child for this class, especially in emergencies.
Atropine is definitely a big one.
It's vital for treating symptomatic bradycardia when the heart's beating too slow and causing problems like dizziness or fainting.
So low heart rate, low blood pressure.
Right.
Or certain types of heart block where the signal isn't getting through properly.
We give it IV, usually 0 .5 milligrams, repeated to the max three milligrams to block that vagal break on the heart and speed it up.
That sounds like a fine line to walk though.
Isn't there a risk of pushing the heart too fast into a bad rhythm?
Absolutely.
That's the challenge.
Atropine has what we call a low therapeutic index.
Meaning the gap between a helpful dose and a harmful dose is small.
Very small.
So continuous ECG monitoring is essential.
You're trying to nudge the heart rate up, but overshoot is a real danger you could trigger serious dysrhythmias or toxicity.
Okay.
Beyond the heart, you mentioned respiratory uses too, and pre -op.
Yes.
Pre -operatively, they're great for drying things up.
Reducing saliva, reducing bronchial secretions.
Makes intubation easier and safer.
Reduces the risk of aspirating secretions during surgery.
Makes sense.
And then the more routine uses for GI and GU issues.
Yep.
For GI, relaxing that smooth muscle and cutting down secretions helps with things like irritable bowel disease or states where there's just too much acid or activity.
And GU, the bladder stuff.
That's a big area.
Overactive bladder, neurogenic bladder, incontinence.
These drugs help the bladder relax and hold more urine before you get that urgent need to go.
Let's talk specifics.
We have natural ones like atropine, scopolamine, and then synthetic ones.
Right.
Natural alkaloids from plants.
And then synthetic or semi -synthetic versions like glycoparalate, oxybutyn, and sultridine.
The synthetics often aim for maybe fewer side effects.
So atropine, we covered the cardiac uses.
Antidote for nerve agent type poisoning.
But who absolutely shouldn't get it?
Key contraindications.
Yeah.
Definitely angle closure, glaucoma, like we said.
Also, any kind of obstruction in the GI or GU tract.
Thinks severe constipation, paralytic alias, or really importantly for older men, BPH, benign prostatic hyperplasia.
The enlarged prostate.
We'll come back to that.
What about scopolamine, the motion sickness patch?
That's its claim to fame.
It's probably the most potent for preventing motion sickness.
You put the patch behind your ear, usually 12 hours before travel, change it every three days.
But it has a bit of a reputation, doesn't it?
CNS effects.
It does.
It's very lipid soluble, meaning it gets into the brain easily.
So sedation, confusion, even delirium are more common with scopolamine compared to some others.
It's also used, sometimes controversially, in palliative care to reduce those respiratory secretions, the death rattle at the end of life.
Okay.
And glycopyrulite.
Primarily used preoperatively, like we discussed, to reduce secretions in the airway and GI tract.
And then the bladder drugs, oxybutynin, tolteridine.
Right.
Those are mainly for overactive bladder.
What's interesting is the development drugs like tolteridine and newer ones were designed to be more selective.
Selective for the bladder.
Yeah.
They target the muscarinic receptors on the bladder.
More specifically than, say, the receptors in your salivary glands.
Meaning less dry mouth.
Exactly.
Dry mouth is often the biggest complaint with older anticholinergics for bladder issues.
These newer ones can reduce that side effect significantly, which is a huge win for patients sticking with the therapy.
Okay.
That flows right into safety.
Before anyone gets one of these drugs, what are the absolute must checks?
Gotta screen carefully.
Known drug allergy, obviously.
Acute asthma, because while they cause bronchodilation, they can sometimes worsen an acute attack,
initially.
Angle closure, glaucoma.
Myasthenia gravis, they can worsen muscle weakness.
And, like we touched on, any existing GI or GU obstruction.
Let's drill down on that obstruction risk.
Why is BPH, the enlarged prostate, such a definite no?
Okay, think about it.
With BPH, the prostate is already squeezing the urethra, making urination difficult.
Right.
Now you give an anticholinergic, it relaxes the bladder wall so it doesn't contract strongly, and it tightens the internal sphincter at the bladder outlet.
Double whammy.
Precisely.
You're making it harder to squeeze urine out, and you're tightening the tap.
It almost guarantees worsening obstruction, often leading to acute urinary retention,
a medical emergency where the person suddenly can't pee at all and needs a catheter.
You're essentially trapping urine in the bladder.
Okay, that paints a very clear picture.
Now, adverse effects.
There's a handy mnemonic mentioned in the source, isn't there?
Ah, yes.
The classic one for the peripheral effects.
It really helps you remember the main side effects.
Can't see, can't pee, can't spit, can't cheat.
Okay, break that down.
Can't see, that's the blurred vision from the myriasis encyclopedia.
Can't pee, urinary retention, can't spit, the really common dry mouth, serostomia, and can't cheat constipation.
Simple.
Memorable.
And you'd add increased heart rate to that list, too.
Definitely.
Tachycardia and potentially dysrhythmias are always a concern.
Now, here's where I think the deep dive gets really critical.
Older adults, you flagged this earlier, there's serious evidence about long -term risks.
This is probably one of the most crucial takeaways, especially for anyone caring for older patients.
They are incredibly sensitive to the CNS effects.
Confusion, cognitive impairment, delirium, these happen much more frequently.
And falls.
Yes.
A significantly increased risk of falls, partly due to the blurred vision, maybe some dizziness or sedation, disorientation.
It's such a known risk that anticholinergics are prominently listed on the BEERS criteria.
Which flags potentially inappropriate medications for older adults.
Exactly, it's a major red flag.
And the source material connects long -term use to dementia.
That sounds alarming.
It is, and the evidence is concerning.
The source points to studies showing high cumulative use, meaning taking these drugs regularly for, say, three years or more, is linked to a substantially higher risk of developing dementia later on.
We're talking around a 54 % higher risk.
Wow.
54%.
That's not insignificant.
Not at all.
This isn't just a minor theoretical risk, it points towards a potential long -term neurocognitive danger with prolonged exposure.
So the nurse's job isn't just managing the immediate side effects like dry mouth, but thinking about this cumulative anticholinergic burden over time, what's the thinking behind why this increases dementia risk?
Well, the leading theory focuses on acetylcholine's role in the brain.
It's vital for learning, memory, attention, cognitive processing.
Right.
Since these drugs can cross the blood -brain barrier and block those crucial muscarinic receptors, especially a subtype called M1,
the idea is that chronic blockade essentially disrupts the brain's communication networks needed for cognition.
So starving the brain of that cholinergic signal over years.
Kind of.
That chronic deprivation, especially layered on top of normal age -related changes, seems to potentially accelerate the underlying processes that lead to dementia.
It really underscores why we need to be so careful.
Lowest effective dose, shortest possible duration, especially in anyone over 65.
It's non -negotiable, really.
That definitely reframes the risk assessment.
Okay, let's talk about overdose, given that low therapeutic index you mentioned.
Right.
Small safety margin means overdose is a real emergency.
Treatment is mainly supportive and symptomatic.
Keep a close eye on the heart with continuous ECG monitoring.
If the overdose was recent and oral, maybe gastric lavage, pumping the stomach, or activated charcoal to bind the drug.
Is there a specific antidote?
There is.
It's a cholinergic drug called physostigmine.
So it does the opposite.
Exactly.
The problem is too little H effect because the receptors are blocked.
Physostigmine is an anti -choline esterase.
It stops the enzyme that normally breaks down H -eat.
Ah, so it lets the natural H -eat build up and hopefully out -compete the blocker.
That's the idea.
Flood the receptors with aphiate.
But its use is actually quite controversial.
Why is that?
Because physostigmine itself can cause severe side effects, like seizures or even cardiac arrest.
So it's usually reserved only for really severe cases with extreme delirium or agitation when the benefits are thought to outweigh those significant risks.
Got it.
And we can't forget drug interactions.
Taking these with other drugs that also have anticholinergic effects.
That's a huge issue.
Think about common ones.
Many antihistamines, especially older ones like divinidramine, tricyclic antidepressants, some muscle relaxants.
So they stack up.
They absolutely stack up.
It leads to additive effects, significantly increasing that anticholinergic burden we talked about.
Pushes the patient much closer to toxicity, cognitive problems, urinary retention, constipation, and that risk of overheating we need to discuss.
Right.
Let's wrap up with patient teaching.
As someone starting one of these meds, what are the absolute need -to -knows for safety, starting with that guaranteed dry mouth?
Yeah, xerostomy is almost a given.
They need practical tips.
Frequent sips of water, good oral hygiene is crucial.
Sugar -free gum or hard candy can help stimulate saliva.
And really important, regular dental checkups.
Chronic dry mouth raises the risk for cavities significantly.
Okay.
And the second big one you hinted at, heat intolerance.
This sounds really serious, especially for older folks.
It is potentially life -threatening.
These drugs block sweating.
Sweating is cholinergic.
It is.
A parasympathetic function needed for cooling down.
If you block it, the body can't regulate its temperature effectively.
Risk of hyperthermia, heat exhaustion, even heat stroke goes way up.
So the advice is?
Avoid hot weather, hot cubs, saunas, strenuous exercise in the heat.
Stay in air conditioning if possible during hot spills.
Older adults are particularly vulnerable here.
Okay.
And vision and just general administration tips.
Definitely wear sunglasses.
The dilated pupils make eyes very sensitive to light.
And a big one.
Avoid driving or operating machinery if they feel drowsy or have blurred vision.
Safety first.
And for specific drugs like the scopolamine patch.
Alright, remind them to apply it behind the ear.
Rotate sites with each new patch to avoid skin irritation.
Put it on about 12 hours before needed for travel.
And change it every three days.
For something like oxybutynine, timing with meals might matter.
Usually take it an hour before or two hours after eating.
This has been incredibly thorough.
A really powerful but definitely risky class of drugs.
It really is.
So to kind of boil it down, cholinergic blockers compete with HE at muscarinic receptors.
This lets the sympathetic system dominate, leading to those peripheral effects.
Can't see, can't pee, can't spit, can't stretch, plus heart rate changes.
Nursing assessment is key checking for contraindications like glaucoma, BPH, obstructions.
And always, always being vigilant about side effects, especially the CNS risks and heat intolerance in older adults.
So here's the final thought for you, our listeners.
We've talked about this compelling, honestly quite disturbing evidence linking cumulative anticholinergic use to that 54 % higher dementia risk.
So the question is, what proactive ethical steps should you always take working with your patients to carefully weigh the benefits against that potential long -term cognitive risk?
How do we ensure we're truly using these drugs safely?
That's something critical to reflect on.
Thank you for joining us for this deep dive.
We'll catch you on the next one.
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
Using this chapter to study? Last Minute Lecture is free and student-run. If it helped, consider supporting the project.
Support LML ♥Related Chapters
- Muscarinic AntagonistsLehne's Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants
- Adrenergic-Blocking Drugs – Beta & Alpha BlockersLilley's Pharmacology for Canadian Health Care Practice
- Antiepileptic Drugs – Seizure Control & MechanismsLilley's Pharmacology for Canadian Health Care Practice
- Antipsychotic Drugs: Uses & EffectsPsychiatric Nursing
- Cholinergic AntagonistsLippincott Illustrated Reviews: Pharmacology
- Cholinergic Drugs – The Parasympathetic SystemLilley's Pharmacology for Canadian Health Care Practice